U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06834152) titled 'Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer (X-SMILE)' on Feb. 06.
Brief Summary: The aim of this phase II international multicenter study is to evaluate the safety, feasibility, and efficacy of CT or MRI-adaptive SBRT, delivered in five weekly fractions, in patients with newly diagnosed localized prostate cancer who have lower urinary tract symptoms and/or prostatic hyperplasia.
Study Start Date: March 01, 2024
Study Type: OBSERVATIONAL
Condition:
Localized Prostate Carcinoma
Prostate Cancer (Adenocarcinoma)
Prostate Hyperplasia
Lower Urinary Track Symptoms
Recruitment Status: RECRUITING
Spons...